{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:37:51Z","timestamp":1784831871873,"version":"3.55.0"},"reference-count":58,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2022,12,12]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Advanced heart failure patients suffer with breathlessness and peripheral oedema, which are frequently treated with parenteral diuretics despite limited evidence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To analyse the effectiveness of parenteral diuretics on breathlessness and peripheral oedema in advanced heart failure patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched Embase, MEDLINE(R), PsycINFO, CINAHL and CENTRAL from their respective inceptions to 2021, and performed handsearching, citation searching and grey literature search; limited to English publications. Selection criteria included parenteral (intravenous\/subcutaneous) diuretic administration in advanced heart failure patients (New York Heart Association class III\u2013IV). Two authors independently assessed articles for inclusion; one author extracted data. Data were synthesised through narrative synthesis or meta-analysed as appropriate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>4646 records were screened; 6 trials (384 participants) were included. All were randomised controlled trials (RCTs) comparing intravenous continuous furosemide infusion (CFI) versus intravenous bolus furosemide infusion (BFI). Improvement in breathlessness and peripheral oedema (two studies, n=161, OR 2.80, 95%\u2009CI 1.45 to 5.40; I<jats:sup>2<\/jats:sup>=0%), and increase in urine output (four studies, n=234, mean difference, MD 344.76, 95%\u2009CI 132.87 to 556.64; I<jats:sup>2<\/jats:sup>=44%), were statistically significant in favour of CFI. Significantly lower serum potassium was found in BFI compared with CFI (three studies, n=194, MD \u22120.20, 95%\u2009CI \u22120.38 to \u22120.01; I<jats:sup>2<\/jats:sup>=0%). There was no difference between CFI and BFI on reduction in weight, renal function or length of hospital stay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>CFI appears to improve congestion in advanced heart failure patients in the short term. Available data came from small trials. Larger, prospective RCTs are recommended to address the evidence gap.<\/jats:p><\/jats:sec>","DOI":"10.1136\/spcare-2022-003863","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T18:20:26Z","timestamp":1672424426000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Advanced heart failure: parenteral diuretics for breathlessness and peripheral oedema \u2013 systematic review"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4300-1890","authenticated-orcid":false,"given":"Alex","family":"Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1506-7262","authenticated-orcid":false,"given":"Adejoke O","family":"Oluyase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Below","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5338-8107","authenticated-orcid":false,"given":"Sabrina","family":"Bajwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"key":"2024051713095976000_14.1.1.1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.025270"},{"key":"2024051713095976000_14.1.1.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.2.194"},{"key":"2024051713095976000_14.1.1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.06.038"},{"key":"2024051713095976000_14.1.1.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(02)00034-X"},{"key":"2024051713095976000_14.1.1.5","doi-asserted-by":"publisher","DOI":"10.1177\/0269216317734435"},{"key":"2024051713095976000_14.1.1.6","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/ejhf.1594","article-title":"Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis","volume":"21","author":"Jones","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2024051713095976000_14.1.1.7","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1858"},{"key":"2024051713095976000_14.1.1.8","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X11309020005"},{"key":"2024051713095976000_14.1.1.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2024051713095976000_14.1.1.10","unstructured":"National Institute for Health and Care Excellence (NICE) . Chronic heart failure in adults: diagnosis and management, 2018. Available: https:\/\/www.nice.org.uk\/guidance\/ng106\/resources\/chronic-heart-failure-in-adults- diagnosis-and-management-pdf-66141541311685 [Accessed 25 Nov 2021]."},{"key":"2024051713095976000_14.1.1.11","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfp041"},{"key":"2024051713095976000_14.1.1.12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"2024051713095976000_14.1.1.13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cvr\/cvz200","article-title":"Palliative care for people living with heart failure: European association for palliative care Task force expert position statement","volume":"116","author":"Sobanski","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2024051713095976000_14.1.1.14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10741-018-9760-6","article-title":"Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review","volume":"24","author":"Afari","year":"2019","journal-title":"Heart Fail Rev"},{"key":"2024051713095976000_14.1.1.15","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cardfail.2019.11.013","article-title":"Continuous infusion versus intermittent boluses of furosemide in acute heart failure: a systematic review and meta-analysis","volume":"26","author":"Chan","year":"2020","journal-title":"J Card Fail"},{"key":"2024051713095976000_14.1.1.16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/anae.14038","article-title":"Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials","volume":"73","author":"Ng","year":"2018","journal-title":"Anaesthesia"},{"key":"2024051713095976000_14.1.1.17","first-page":"CD003838","article-title":"Diuretics for heart failure","author":"Faris","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2024051713095976000_14.1.1.18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ehf2.12677","article-title":"Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature","volume":"7","author":"Wierda","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2024051713095976000_14.1.1.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"2024051713095976000_14.1.1.20","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1236"},{"key":"2024051713095976000_14.1.1.21","unstructured":"Higgins JPT , Savovi\u0107 J , Page MJ , et al . Chapter 8: Assessing risk of bias in a randomized trial. In: Cochrane Handbook for systematic reviews of interventions version 6.2. Cochrane, 2021. www.training.cochrane.org\/handbook"},{"key":"2024051713095976000_14.1.1.22","unstructured":"Popay J , Roberts H , Sowden A , et al . Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC methods programme, 2006."},{"key":"2024051713095976000_14.1.1.23","unstructured":"RevMan . [Computer program], Nordic Cochrane Centre, Cochrane Manager 5 (RevMan 5). Version 5.4.1. Copenhagen: Nordic Cochrane Centre, Cochrane, 2020."},{"key":"2024051713095976000_14.1.1.24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11739-014-1112-5","article-title":"Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction","volume":"10","author":"Palazzuoli","year":"2015","journal-title":"Intern Emerg Med"},{"key":"2024051713095976000_14.1.1.25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ehj.2017.12.005","article-title":"Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: effect on thoracic fluid content","volume":"70","author":"Ragab","year":"2018","journal-title":"Egypt Heart J"},{"key":"2024051713095976000_14.1.1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2009.11.005"},{"key":"2024051713095976000_14.1.1.27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00392-019-01521-y","article-title":"Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial","volume":"109","author":"Frea","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"2024051713095976000_14.1.1.28","first-page":"2814","article-title":"A study on continuous infusion versus intermittent bolus dosing of furosemide in hospitalized heart failure patients","volume":"14","author":"Jaya Shree","year":"2021","journal-title":"Research Journal of Pharmacy and Technology"},{"key":"2024051713095976000_14.1.1.29","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/ehf2.13286","article-title":"Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction","volume":"8","author":"Zheng","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2024051713095976000_14.1.1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.07.003"},{"key":"2024051713095976000_14.1.1.31","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq045"},{"key":"2024051713095976000_14.1.1.32","doi-asserted-by":"publisher","DOI":"10.5049\/EBP.2015.13.1.17"},{"key":"2024051713095976000_14.1.1.33","unstructured":"Johnson M . Heart failure and palliative care: a team approach. 2nd ed. Taylor & Francis Group, 2017."},{"key":"2024051713095976000_14.1.1.34","unstructured":"Guideline for the administration of subcutaneous furosemide in the community setting, 2017. Available: http:\/\/www.yorkandscarboroughformulary.nhs.uk\/docs\/BNF\/02\/Guidelines%20for%20subcutaneous%20Furosemide%20in%20the%20community.pdf [Accessed 01 Jan 2021]."},{"key":"2024051713095976000_14.1.1.35","unstructured":"Guidance for the use of subcutaneous furosemide by continuous infusion for heart failure in community settings. Available: https:\/\/www.heartfailurehubscotland.co.uk\/wp-content\/uploads\/2016\/04\/NHS-Highlands-SC-furosemide-policy3.pdf [Accessed 01 Jan 2021]."},{"key":"2024051713095976000_14.1.1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2005.12.001"},{"key":"2024051713095976000_14.1.1.37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0269216317706426","article-title":"Strategies to address the shortcomings of commonly used advanced chronic heart failure descriptors to improve recruitment in palliative care research: a parallel mixed-methods feasibility study","volume":"32","author":"Kane","year":"2018","journal-title":"Palliat Med"},{"key":"2024051713095976000_14.1.1.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcnurse.2010.12.002"},{"key":"2024051713095976000_14.1.1.39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/JCN.0b013e3182784cc0","article-title":"Lessons from the field: challenges in accruing hospice heart failure patients to intervention research","volume":"29","author":"Zambroski","year":"2014","journal-title":"J Cardiovasc Nurs"},{"key":"2024051713095976000_14.1.1.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2007.10.022"},{"key":"2024051713095976000_14.1.1.41","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz835"},{"key":"2024051713095976000_14.1.1.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2019-002158"},{"key":"2024051713095976000_14.1.1.43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2020-002803"},{"key":"2024051713095976000_14.1.1.44","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311399490"},{"key":"2024051713095976000_14.1.1.45","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s12265-021-10173-1","article-title":"Efficacy and safety of subcutaneous infusion of Non-formulated furosemide in patients with worsening heart failure: a real-world study","volume":"15","author":"Civera","year":"2022","journal-title":"J Cardiovasc Transl Res"},{"key":"2024051713095976000_14.1.1.46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jacbts.2017.10.001","article-title":"Subcutaneous furosemide in heart failure: pharmacokinetic characteristics of a newly buffered solution","volume":"3","author":"Sica","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"2024051713095976000_14.1.1.47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.12.1319"},{"key":"2024051713095976000_14.1.1.48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/ebmed-2016-110401","article-title":"New evidence pyramid","volume":"21","author":"Murad","year":"2016","journal-title":"Evid Based Med"},{"key":"2024051713095976000_14.1.1.49","doi-asserted-by":"publisher","DOI":"10.1136\/emj.20.2.164"},{"key":"2024051713095976000_14.1.1.50","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfp194"},{"key":"2024051713095976000_14.1.1.51","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/ejhf.1994","article-title":"Integration of a palliative approach into heart failure care: a European Society of cardiology heart failure association position paper","volume":"22","author":"Hill","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2024051713095976000_14.1.1.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.08.036"},{"key":"2024051713095976000_14.1.1.53","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.4.374"},{"key":"2024051713095976000_14.1.1.54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60230-X"},{"key":"2024051713095976000_14.1.1.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2013.10.018"},{"key":"2024051713095976000_14.1.1.56","unstructured":"Centre for Palliative Care Research and Education Queensland Health . Management of subcutaneous infusions in palliative care, 2010. Available: https:\/\/www.health.qld.gov.au\/__data\/assets\/pdf_file\/0026\/152909\/modules.pdf [Accessed 01 Jan 2021]."},{"key":"2024051713095976000_14.1.1.57","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2011-000199"},{"key":"2024051713095976000_14.1.1.58","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f4779"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2022-003863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:42:01Z","timestamp":1715985721000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2022-003863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2,21]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/spcare-2022-003863"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2022-003863","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}